Organovo Holdings Inc
NASDAQ:ONVO

Watchlist Manager
Organovo Holdings Inc Logo
Organovo Holdings Inc
NASDAQ:ONVO
Watchlist
Price: 1.87 USD -8.33% Market Closed
Market Cap: 3.2m USD

Relative Value

ONVO doesn't have a meaningful market cap.

The Relative Value of one ONVO stock under the Base Case scenario is 0.82 USD. Compared to the current market price of 1.87 USD, Organovo Holdings Inc is Overvalued by 56%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ONVO Relative Value
Base Case
0.82 USD
Overvaluation 56%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
61
vs Industry
22
Median 3Y
68.9
Median 5Y
50.8
Industry
7.2
Forward
18.3
vs History
vs Industry
Median 3Y
-1.4
Median 5Y
-2.9
Industry
23.2
Forward
-2.4
vs History
vs Industry
Median 3Y
-1.5
Median 5Y
-3.7
Industry
19.3
vs History
vs Industry
Median 3Y
-1.5
Median 5Y
-3.6
Industry
22.5
vs History
17
vs Industry
6
Median 3Y
2.7
Median 5Y
3.4
Industry
2.7
vs History
57
vs Industry
21
Median 3Y
48.3
Median 5Y
31.3
Industry
7.5
Forward
11.6
vs History
28
vs Industry
16
Median 3Y
0
Median 5Y
0
Industry
9.4
vs History
vs Industry
21
Median 3Y
-0.9
Median 5Y
-1.4
Industry
4.6
vs History
vs Industry
20
Median 3Y
-0.9
Median 5Y
-1.4
Industry
4.5
Forward
-0.1
vs History
vs Industry
21
Median 3Y
-1.1
Median 5Y
-1.9
Industry
4.9
vs History
vs Industry
18
Median 3Y
-1
Median 5Y
-1.8
Industry
3.7
vs History
95
vs Industry
44
Median 3Y
4.8
Median 5Y
6.2
Industry
4.9

Multiples Across Competitors

ONVO Competitors Multiples
Organovo Holdings Inc Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Organovo Holdings Inc
NASDAQ:ONVO
3.2m USD 26.1 -0.3 -0.2 -0.2
FR
Pharnext SCA
OTC:PNEXF
6T USD 34 361 436.7 -163 314.8 -198 316.3 -196 053.2
US
Abbvie Inc
NYSE:ABBV
337.5B USD 5.9 81.2 15.4 22.8
US
Amgen Inc
NASDAQ:AMGN
158.7B USD 4.7 26.8 14.4 23.7
US
Gilead Sciences Inc
NASDAQ:GILD
136.9B USD 4.8 23 10 13.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
117B USD 10.5 -118.3 25.2 26.4
US
Epizyme Inc
F:EPE
94.1B EUR 2 050.2 -523.2 -569.7 -554.5
AU
CSL Ltd
ASX:CSL
116.1B AUD 4.9 27.4 16.9 21.2
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
57.3B USD 4.1 12.7 11.3 12.7
US
Seagen Inc
F:SGT
39.3B EUR 19.7 -60.6 -65.3 -58.9
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
40.1B USD 17.1 -148.8 -666.4 -333.9
P/S Multiple
Revenue Growth P/S to Growth
US
Organovo Holdings Inc
NASDAQ:ONVO
Average P/S: 3 123 962.2
26.1
29%
0.9
FR
Pharnext SCA
OTC:PNEXF
34 361 436.7
N/A N/A
US
Abbvie Inc
NYSE:ABBV
5.9
8%
0.7
US
Amgen Inc
NASDAQ:AMGN
4.7
4%
1.2
US
Gilead Sciences Inc
NASDAQ:GILD
4.8
3%
1.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
10.5
10%
1.1
US
E
Epizyme Inc
F:EPE
2 050.2
N/A N/A
AU
CSL Ltd
ASX:CSL
4.9
7%
0.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
4.1
4%
1
US
S
Seagen Inc
F:SGT
19.7
30%
0.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
17.1
29%
0.6
P/E Multiple
Earnings Growth PEG
US
Organovo Holdings Inc
NASDAQ:ONVO
Average P/E: 34.2
Negative Multiple: -0.3
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -163 314.8 N/A N/A
US
Abbvie Inc
NYSE:ABBV
81.2
88%
0.9
US
Amgen Inc
NASDAQ:AMGN
26.8
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
23
188%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -118.3 N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -523.2 N/A N/A
AU
CSL Ltd
ASX:CSL
27.4
16%
1.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
12.7
7%
1.8
US
S
Seagen Inc
F:SGT
Negative Multiple: -60.6 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -148.8 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Organovo Holdings Inc
NASDAQ:ONVO
Average EV/EBITDA: 15.5
Negative Multiple: -0.2
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -198 316.3 N/A N/A
US
Abbvie Inc
NYSE:ABBV
15.4
13%
1.2
US
Amgen Inc
NASDAQ:AMGN
14.4
17%
0.8
US
Gilead Sciences Inc
NASDAQ:GILD
10
6%
1.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.2
17%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -569.7 N/A N/A
AU
CSL Ltd
ASX:CSL
16.9
11%
1.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
11.3
11%
1
US
S
Seagen Inc
F:SGT
Negative Multiple: -65.3 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -666.4 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Organovo Holdings Inc
NASDAQ:ONVO
Average EV/EBIT: 20.1
Negative Multiple: -0.2
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -196 053.2 N/A N/A
US
Abbvie Inc
NYSE:ABBV
22.8
29%
0.8
US
Amgen Inc
NASDAQ:AMGN
23.7
32%
0.7
US
Gilead Sciences Inc
NASDAQ:GILD
13.8
11%
1.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26.4
17%
1.6
US
E
Epizyme Inc
F:EPE
Negative Multiple: -554.5 N/A N/A
AU
CSL Ltd
ASX:CSL
21.2
14%
1.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
12.7
11%
1.2
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.9 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -333.9 N/A N/A